Abstract:This study examines in vivo the role and functional interrelationships of components regulating exit from the G1 resting phase into the DNA synthetic (S) phase of the cell cycle. Our approach made use of several key experimental attributes of the developing mouse lens, namely its strong dependence on pRb in maintenance of the postmitotic state, the down-regulation of cyclins D and E and up-regulation of the p57(KIP2) inhibitor in the postmitotic lens fiber cell compartment, and the ability to target transgene expression to this compartment. These attributes provide an ideal in vivo context in which to examine the consequences of forced cyclin expression and/or of loss of p57(KIP2) inhibitor function in a cellular compartment that permits an accurate quantitation of cellular proliferation and apoptosis rates in situ. Here, we demonstrate that, despite substantial overlap in cyclin transgene expression levels, D-type and E cyclins exhibited clear functional differences in promoting entry into S phase. In general, forced expression of the D-type cyclins was more efficient than cyclin E in driving lens fiber cells into S phase. In the case of cyclins D1 and D2, ectopic proliferation required their enhanced nuclear localization through CDK4 coexpression. High nuclear levels of cyclin E and CDK2, while not sufficient to promote efficient exit from G1, did act synergistically with ectopic cyclin D/CDK4. The functional differences between D-type and E cyclins was most evident in the p57(KIP2)-deficient lens wherein cyclin D overexpression induced a rate of proliferation equivalent to that of the pRb null lens, while overexpression of cyclin E did not increase the rate of proliferation over that induced by the loss of p57(KIP2) function. These in vivo analyses provide strong biological support for the prevailing view that the antecedent actions of cyclin D/CDK4 act cooperatively with cyclin E/CDK2 and antagonistically with p57(KIP2) to regulate the G1/S transition in a cell type highly dependent upon pRb.

The oscillation of mitotic kinase governs cell cycle latches in mammalian cells

From quiescence to proliferation: Cdk oscillations drive the mammalian cell cycle

Why minimal is not optimal: Driving the mammalian cell cycle—and drug discovery—with a physiologic CDK control network

Cell cycle, CDKs and cancer: a changing paradigm

Cell Cycle Progression Mechanisms: Slower Cyclin-D/cdk4 Activation and Faster Cyclin-E/cdk2.

Identification of a new cell cycle variant during multiciliated cell differentiation

Balancing Plk1 activity levels: The secret of synchrony between the cell and the centrosome cycle

Canonical and Atypical E2Fs Regulate the Mammalian Endocycle

Core control principles of the eukaryotic cell cycle

Cell Cycle Control by a Minimal Cdk Network

Newton's cradle: Cell cycle regulation by two mutually inhibitory oscillators

CDK5-cyclin B1 regulates mitotic fidelity

The balance between cell cycle arrest and cell proliferation: control by the extracellular matrix and by contact inhibition

Newton′s Cradle: Cell Cycle Regulation by Two Mutually Inhibitory Oscillators

Slower CDK4 and faster CDK2 activation in the cell cycle

Cdt1 revisited: complex and tight regulation during the cell cycle and consequences of deregulation in mammalian cells

On the assembly of the mitotic spindle, bistability and hysteresis

Spatiotemporal Orchestration of Mitosis by Cyclin-Dependent Kinase

Cyclin K regulates prereplicative complex assembly to promote mammalian cell proliferation

An alternative cell cycle coordinates multiciliated cell differentiation

Cyclin D- and E-Dependent Kinases and the P57(Kip2) Inhibitor: Cooperative Interactions in Vivo